Veru (VERU) Accumulated Expenses (2010 - 2026)
Veru (VERU) posted quarterly Accumulated Expenses of $382876.0 for Q1 2026, down 80.73% year-over-year from $2.0 million in Q1 2025, and down 91.58% quarter-over-quarter from $4.5 million in Q4 2025.
Veru (VERU) Accumulated Expenses (2010 - 2026) Analysis & Trends
Veru (VERU) has reported Accumulated Expenses for 17 consecutive years, with $382876.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses fell 80.73% year-over-year to $382876.0; the TTM figure through Mar 2026 stood at $382876.0 (down 80.73% YoY), while the FY2025 annual figure was $394529.0, down 41.09% from the prior year.
- Accumulated Expenses slipped to $382876.0 in Q1 2026 per VERU's latest filing, from $4.5 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $7.1 million in Q4 2022 and bottomed at $100000.0 in Q3 2023.
- Historically, Accumulated Expenses has averaged $2.7 million across 5 years, with a median of $2.4 million in 2022.
- Annual changes were most pronounced in 2023 — Accumulated Expenses tumbled 98.33% — and 2024, when it surged 569.69%.
- Veru's Accumulated Expenses stood at $7.1 million in 2022, then slumped by 69.82% to $2.2 million in 2023, then slumped by 30.21% to $1.5 million in 2024, then soared by 202.46% to $4.5 million in 2025, then slumped by 91.58% to $382876.0 in 2026.
- Business Quant data shows VERU's Accumulated Expenses at $382876.0 in Q1 2026, $4.5 million in Q4 2025, and $394529.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.72 Mn |
| Mar 31, 2026 | 382,876.00 |
| Dec 31, 2025 | 4.55 Mn |
| Sep 30, 2025 | 394,529.00 |
| Jun 30, 2025 | 2.78 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 669,685.00 |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.68 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 3.55 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Dec 31, 2022 | 7.14 Mn |
| Sep 30, 2022 | 5.99 Mn |
| Jun 30, 2022 | 4.02 Mn |
| Mar 31, 2022 | 2.39 Mn |
| Dec 31, 2021 | 2.02 Mn |
| Sep 30, 2021 | 4.99 Mn |